Rockwell Medical (RMTI) Interest Expenses (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Interest Expenses came in at $5.8 million in Q1 2026, up 944.93% YoY from $552000.0 in Q1 2025, and up 344.72% on a QoQ basis from $1.3 million in Q4 2025.
Rockwell Medical (RMTI) Interest Expenses (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Interest Expenses data on file, last reported at $5.8 million in Q1 2026.
- Quarterly Interest Expenses rose 944.93% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 944.93% YoY) and the FY2025 annual result came in at $6.9 million, down 91.91% from the prior year.
- Interest Expenses improved to $5.8 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $5.8 million in Q1 2026 to a low of -$118000.0 in Q4 2024.
- A 5-year average of $860235.3 and a median of $478000.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses plunged 149.09% — and 2023, when it soared 4203.7%.
- Tracing RMTI's Interest Expenses over 5 years: stood at -$27000.0 in 2022, then soared by 4203.7% to $1.1 million in 2023, then sank by 110.65% to -$118000.0 in 2024, then soared by 1199.15% to $1.3 million in 2025, then jumped by 344.72% to $5.8 million in 2026.
- The last three Interest Expenses figures came in at $5.8 million (Q1 2026), $1.3 million (Q4 2025), and $552000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Rockwell Medical | 29.93 Mn | 5.13 Mn | 3.24 Mn | 281,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.30 Mn |
| Jun 30, 2026 | 5.30 Mn |
| Mar 31, 2026 | 5.77 Mn |
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 552,000.00 |
| Sep 30, 2025 | 552,000.00 |
| Jun 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 552,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | 449,000.00 |
| Sep 30, 2024 | 449,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Mar 31, 2024 | 437,000.00 |
| Mar 31, 2024 | 437,000.00 |